A hospital is revising its high-alert medication safety program. For each proposed policy statement, identify whether it is an evidence-based risk control or needs revision.
Matrix
Choose your responses, then check the answer.
Explanation
A high-alert designation does not mean every dose or every medication automatically requires an independent double check. ISMP recommends layered system controls and limiting independent double checks to selected high-alert medications or workflows with the greatest organizational risk, such as IV insulin, heparin infusions, opioid infusions, and chemotherapy when designated by local policy. Each clinician performs the check independently, including critical patient, medication, concentration, dose, route, rate, line, and pump variables, then compares results and resolves discrepancies. Independent double checks should complement rather than replace standardization, pharmacy review, barcode scanning, smart-pump limits, and outcome monitoring.
Correct Answer Use layered safety controls, reserve independent double checks for selected greatest-risk workflows under the organization's policy, perform each check independently, and measure whether the process prevents harm. Revise any policy that requires the same double-check list everywhere or relies on double checks as the only safety layer.
Why It Fits High-alert medications cause more serious harm when errors occur, but a high-alert label alone does not create a universal double-check mandate for every dose. ISMP recommends selecting the highest-risk workflows within each organization and combining checks with stronger system controls.
Clinical Picture An independent double check is a final comparison between two separately completed assessments. It is not one clinician reading values aloud while the other agrees, and it cannot repair a poorly designed medication system by itself.
Memory Link Select the highest risk, check independently, compare afterward, and keep the system safeguards.
NCLEX Rule Follow the organization's approved medication policy while recognizing the safety principle behind it. Avoid absolute claims that ISMP or The Joint Commission requires one identical independent-double-check list in every hospital.
Why the Alternatives Fail Applying double checks to every high-alert medication dilutes attention and increases work without targeting the greatest risk. Replacing barcode scanning, standard concentrations, smart-pump limits, or pharmacy review with a double check removes stronger defenses.
Source
1ISMP 2024-2025 Targeted Medication Safety Best Practices for Hospitals
The medication-safety committee is applying ISMP guidance. The organization uses standard concentrations, barcode scanning, smart-pump limits, pharmacy review, and independent double checks for selected highest-risk workflows.
High-alert medication — Drug with high risk of significant patient harm if used in error; includes insulin, heparin, opioids, chemo, NMBA.
Independent double-check (IDC) — Two qualified clinicians SEPARATELY verify the order, drug, dose, route, patient, line, and pump before administration.
ISMP high-alert list — Institute for Safe Medication Practices list of medications requiring extra safeguards.